Literature DB >> 3593905

Physiological pharmacokinetics and pharmacodynamics of (+/-)-verapamil in female rats.

E L Todd, D R Abernethy.   

Abstract

Tissue distribution and pharmacodynamics of verapamil were evaluated during steady state intravenous (i.v.) infusion and after single dose intraperitoneal (i.p.) drug administration to female Sprague-Dawley rats. In one group of rats, verapamil was infused to a steady state concentration at which time animals were killed. Verapamil-induced decreases in mean arterial pressure (MAP) were monitored during infusion and correlated with concomitantly obtained plasma verapamil concentrations. Tissue (lung, liver, renal medulla, renal cortex, cardiac muscle, skeletal muscle, perirenal fat, brain stem, cerebral cortex, and cerebellum) and plasma samples were obtained immediately after animals were killed and verapamil and norverapamil concentrations determined. Another group of rats, after receiving i.p. verapamil, were killed at 1, 3, 5, 19, and 24 h. Elimination from each tissue evaluated was described by a first order process. Elimination half-life of verapamil was similar among plasma and tissues evaluated (1.5 to 2.2 h). The per cent verapamil not bound to plasma proteins was concentration-independent and similar between rats receiving i.p. (mean +/- S.D.) (2.28 +/- 0.72 per cent) and i.v. (2.08 +/- 0.03 per cent) verapamil. MAP and verapamil concentration in plasma (r = 0.75; p less than 0.01) and cardiac muscle (r = -0.82; p less than 0.01) were inversely correlated in a highly significant fashion during both i.v. and i.p. drug administrations. The tissue-to-plasma distribution ratio for verapamil and norverapamil was similar among animals receiving i.p. verapamil at all points of sampling, suggesting distribution equilibrium had been achieved. After steady state i.v. infusion, both verapamil and norverapamil tissue: plasma concentration ratios were greater than after i.p. administration. Higher tissue: plasma verapamil concentration ratios after i.v. administration than after i.p. administration suggest either only a pseudoequilibrium is attained after i.p. administration or that determinants of tissue distribution of racemic verapamil differ with different routes of drug administration. In these studies, MAP provided a reasonable pharmacodynamic marker for verapamil tissue and plasma concentrations.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3593905     DOI: 10.1002/bdd.2510080309

Source DB:  PubMed          Journal:  Biopharm Drug Dispos        ISSN: 0142-2782            Impact factor:   1.627


  7 in total

1.  Exercise and the pharmacokinetics of propranolol, verapamil and atenolol.

Authors:  M A van Baak; J M Mooij; P M Schiffers
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

2.  Influence of famotidine on verapamil pharmacokinetics in rats.

Authors:  Kamal M Matar
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2005 Jul-Sep       Impact factor: 2.441

3.  Enantioselective kinetics of verapamil and norverapamil in isolated perfused rat livers.

Authors:  R Mehvar; J M Reynolds; M A Robinson; J A Longstreth
Journal:  Pharm Res       Date:  1994-12       Impact factor: 4.200

4.  Effects of calcium channel blockers on the development of early rat postimplantation embryos in culture.

Authors:  G Stein; M K Srivastava; H J Merker; D Neubert
Journal:  Arch Toxicol       Date:  1990       Impact factor: 5.153

5.  The liver partition coefficient-corrected inhibitory quotient and the pharmacokinetic-pharmacodynamic relationship of directly acting anti-hepatitis C virus agents in humans.

Authors:  Jianmin Duan; Gordon Bolger; Michel Garneau; Ma'an Amad; Joëlle Batonga; Hélène Montpetit; François Otis; Martin Jutras; Nicole Lapeyre; Manon Rhéaume; George Kukolj; Peter W White; Richard C Bethell; Michael G Cordingley
Journal:  Antimicrob Agents Chemother       Date:  2012-08-06       Impact factor: 5.191

6.  BDNF release and signaling are required for the antidepressant actions of GLYX-13.

Authors:  T Kato; M V Fogaça; S Deyama; X-Y Li; K Fukumoto; R S Duman
Journal:  Mol Psychiatry       Date:  2017-12-05       Impact factor: 15.992

7.  Verapamil Inhibits Mitochondria-Induced Reactive Oxygen Species and Dependent Apoptosis Pathways in Cerebral Transient Global Ischemia/Reperfusion.

Authors:  Ehsan Jangholi; Zahra Nadia Sharifi; Mohammad Hoseinian; Mohammad-Reza Zarrindast; Hamid Reza Rahimi; Ashkan Mowla; Hoda Aryan; Mohammad Amin Javidi; Yekta Parsa; Fariborz Ghaffarpasand; Soheila Yadollah-Damavandi; Hamid Zaferani Arani; Farshad Shahi; Shabnam Movassaghi
Journal:  Oxid Med Cell Longev       Date:  2020-10-17       Impact factor: 6.543

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.